Navigation Links
ShangPharma Announces Milestone Achievement in Research Partnership with Hengrui
Date:1/19/2012

uch as oncology, cardiovascular and metabolic diseases, CNS, inflammation, hematology and anesthesiology. For more information, please visit http://www.hrs.com.cn.

About ShangPharma ShangPharma Corporation is a leading China-based contract research organization providing high-quality and cost-effective services for the pharmaceutical and biotechnology industry. It offers a broad range of high-quality, integrated services across the drug discovery and development process to help international and Chinese pharmaceutical and biotechnology companies discover and develop novel drug candidates efficiently. ShangPharma's services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. For more information, please visit www.shangpharma.com.

Safe Harbor: Forward-Looking Statements This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements can be identified by terminology such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "likely to" or other similar expressions. The Company has based these forward-looking statements largely on its current expectations and projections about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs. The quotations from management in this press release contain forward-looking statements. The Company may also make written or oral forward-looking statements in its reports filed or furnished with the U.S. Securities and Exchange Commission, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are
'/>"/>

SOURCE ShangPharma Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ShangPharma Announces Opening of New Facility to Support Lillys Pipeline
2. ShangPharma to Attend Two Upcoming Investor Conferences
3. ShangPharma Announces Third Quarter 2011 Results
4. ShangPharma Purchases Shanghai In-vivo Drug Research Facility from Charles River
5. ShangPharma Corporation Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting
6. ShangPharma Corporation Announces Resignation of a Director
7. ShangPharma Corporation to Hold 2011 Annual General Meeting on October 14, 2011
8. ShangPharma Announces Up to $10 Million Share Repurchase Program
9. ShangPharmas Biologics Division Announces Accelerated Achievement of Milestones for Two Multi-Stage Projects
10. ShangPharma Corporation to Announce First Quarter 2011 Financial Results on May 19, 2011
11. ShangPharma Corporation Files 2010 Annual Report on Form 20-F
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 6, 2015  Rigrodsky & Long, P.A.: ... Pharmaceuticals, Inc. (NASDAQ GM: AERI )? , Did you ... inclusive? , Did you lose money in your investment in ... rights? Rigrodsky & Long, P.A. , ... , announces that a complaint has been filed in the United ...
(Date:5/6/2015)... May 05, 2015 Research and Markets ... of the "Chromatography (Instruments and Reagents) Global ... their offering. Chromatography is an analytical ... component of a complex mixture by differential movement ... the scientists have considered chromatography as an esoteric ...
(Date:5/6/2015)... 2015   CEFALY Technology , the creators of ... authorized for use prior to the onset of migraine ... treatment at the EUROHEADPAIN - Midterm Meeting at the ... , from May 14-17, 2015. On ... a major European research project focused on migraines, ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 2SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 3Global Chromatography (Instruments and Reagents) Market 2015 - Forecasts to 2019 2CEFALY to Present Breakthrough Data in Migraine Treatment at International Headache Society Congress 2
... Masimo (NASDAQ: MASI ) ... month,s issue of the peer-reviewed journal, Annals of ... measurements provide an "effective means for screening at-risk populations ... to invasive blood gas analysis.  The prospective diagnostic accuracy ...
... NEW YORK, April 21, 2011 Amgen (NASDAQ: ... and provided financial guidance for 2015 during a meeting with ... CEO opened the meeting by outlining key elements of the ... advance treatment of serious illness; Make significant and ...
Cached Medicine Technology:New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 2New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 3New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 4New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 5New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 6Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 2Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 3Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 4Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 5Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 6Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 7Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 8
(Date:5/6/2015)... (PRWEB) May 07, 2015 New ... NSF/IPEC/ANSI 363-2014, **FDAnews Webinar**, May 27, 2015 — ... , Most drugs contain 70-90% excipients, which ... agents or other purposes that facilitate the manufacturing ... the pharma industry, combined with a regulatory focus ...
(Date:5/6/2015)... RPS Revolution - a game for the ... true Rock Paper Scissors game - is now taking ... storytelling and easy to learn rules from Rock Paper Scissors, ... favorite. RPS Revolution takes the best parts of ... are grouped in set of three called Trios. Trios like ...
(Date:5/6/2015)... May 06, 2015 As Hilo ... HIMSS EMR Adoption Model, the hospital looked for ... engagement and automate processes. The leadership team realized ... to electronic workflows, patient registration still required patients ... consents. With HIMSS Stage 7 attestation fast approaching, ...
(Date:5/6/2015)... May 05, 2014 (PRWEB) May 06, 2015 ... Lock accepted, on behalf of MEBC, an Alliance ... from JDA Software during FOCUS 2015, JDA’s annual ... across the manufacturing, retail and wholesale distribution sectors. ... that their clients are receiving services that advance ...
(Date:5/6/2015)... The Beryl Institute announces the publication ... Experience Journal (PXJ), an international, open access, peer-reviewed journal ... improving patient experience. The second volume of PXJ supports ... helps align the voices engaged and provides the space ... association with The Beryl Institute, Volume 2, Issue 1 ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — New Standards for Excipient GMPs: Analyzing the Impact of NSF/IPEC/ANSI 363-2014 Webinar, May 27, 2015 2Health News:FDAnews Announces — New Standards for Excipient GMPs: Analyzing the Impact of NSF/IPEC/ANSI 363-2014 Webinar, May 27, 2015 3Health News:RPS Revolution Launches Kickstarter Campaign 2Health News:RPS Revolution Launches Kickstarter Campaign 3Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:MEBC Receives Award for Consulting Excellence in Retail 2Health News:Patient Experience Journal Releases Spring 2015 Issue 2
... therapy of Prostacyclin, Sildenafil, and Bosentan helped a ... enough to receive a liver transplant. It was ... health. These findings are published in the March ... Wiley & Sons. The article is also available ...
... between two closely related strains of the influenza A ... flu epidemics, according to biologists. The findings could help ... lead to seasonal epidemics., Until now, it was believed that ... with influenza viruses that infect birds causes severe ...
... WASHINGTON, March 4 Enrollment in,Consumer-Directed Health Plans ... health care information tools to employees in order,to ... to a study,commissioned by the American Association of ... Inc., (Logo: http://www.newscom.com/cgi-bin/prnh/20060126/CLTH062LOGO ), ...
... BlueCross BlueShield of South,Carolina announced today that the second ... lunchtime hours on Wednesday, April 30, 2008., Blue ... well as,other employers, will encourage their employees to wear ... a 30-minute lunchtime walk., The motivation behind National ...
... launch of the latest fleet golf car and the ... Inc., a leader in,manufacturing execution systems (MES) for the ... online event,titled "Launching the E-Z-GO Fleet Golf Car: Integrating ... will,take place on Thursday, March 6, 2008 at 2:00 ...
... heighten accuracy with Microsoft Dynamics ... ... that AliMed, a producer and catalog-based distributor of medical,products, has chosen ... its business and expanding its interaction with,customers. The technology will enable ...
Cached Medicine News:Health News:A combination therapy of 3 vasodilators may treat portopulmonary hypertension 2Health News:Study uncovers cause of flu epidemics 2Health News:Study uncovers cause of flu epidemics 3Health News:Consumer-Directed Health Plans Continue to Grow as Popular Vehicle to Bring Choice, Flexibility and Access to Consumers 2Health News:Consumer-Directed Health Plans Continue to Grow as Popular Vehicle to Bring Choice, Flexibility and Access to Consumers 3Health News:S.C. BlueCross Announces Second Annual National Walk @ Lunch Day 2Health News:E-Z-GO and Visiprise to Participate in New Product Introduction Event with IndustryWeek 2Health News:E-Z-GO and Visiprise to Participate in New Product Introduction Event with IndustryWeek 3Health News:Medical Products Distributor Gains New Flexibility With Its Selection of Microsoft Dynamics AX and Microsoft Dynamics CRM 2Health News:Medical Products Distributor Gains New Flexibility With Its Selection of Microsoft Dynamics AX and Microsoft Dynamics CRM 3Health News:Medical Products Distributor Gains New Flexibility With Its Selection of Microsoft Dynamics AX and Microsoft Dynamics CRM 4Health News:Medical Products Distributor Gains New Flexibility With Its Selection of Microsoft Dynamics AX and Microsoft Dynamics CRM 5
... The Equalizer With 384 Well Plate Capability ... revolutionary features of the original Equalizerexpandable and equal ... components, and in-lab calibration capabilities. In addition, this ... down to 4.5mm for loading and accessing many ...
... Exp Expandable Tip System A lower ... allows you to perform multi-sample transfers between two ... of a knob, tip spacing can be quickly ... tubes) or 96 well plates. Ergonomic Design ...
... transfer samples from 96-well plates ... Accurately deliver 0.5-5 μl. Complete ... six minutes or less. Compatible ... and other gels with microwell ...
... Equally Spaced, Expandable, Multichannel Pipettor ... pipettors and instantly boosts productivity with an ... the simple adjustment of a slide rod. ... transfer of liquids between vessels with different ...
Medicine Products: